Iantrek

White Plains, United States

Iantrek develops technology for minimally invasive microinvasive glaucoma surgery.

$42.0M raised

Aug 2025

Series C

Top Investors

Civilization VenturesU.S. Venture PartnersaMoon FundVisionary Venture FundSectoral Asset Management

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Iantrek raised?

Iantrek has raised $42.0M in total funding. The most recent round was Series C. The last funding was announced in August 2025.

Who are Iantrek's investors?

Iantrek's investors include Civilization Ventures, U.S. Venture Partners, aMoon Fund, Visionary Venture Fund, Sectoral Asset Management.

Where is Iantrek headquartered?

Iantrek is headquartered in White Plains, United States.

What does Iantrek do?

Iantrek develops technology for minimally invasive microinvasive glaucoma surgery.

What stage is Iantrek at?

Iantrek is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 20, 2025.

MLA

"Iantrek — Funding & Investors." VCBacked, August 20, 2025, https://www.vcbacked.co/company/iantrek. Accessed June 17, 2026.

APA

VCBacked. (2025). Iantrek — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/iantrek

Wikipedia (cite web)

{{cite web |title=Iantrek — Funding & Investors |url=https://www.vcbacked.co/company/iantrek |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 20, 2025.